Riskpilot← Back to searchSign inGet full accessArta Medical AB
ABActiveOrg 5568302235Antennvägen 1 AFinancial leasing · NACE 6491Est. 20100 employees
Revenue 2025
SEK 2M
-27% vs 2024
EBITDA margin
8.7%
-76% vs 2024
Equity ratio
86.7%
Financial strength
Net profit 2025
SEK 225K
-26% vs 2024
| Revenue | SEK 2M | -27% |
| EBITDA | SEK 173K | -76% |
| Net profit | SEK 225K | -26% |
| Total assets | SEK 2,3M | -2% |
| Equity | SEK 2M | +13% |
| Employees | 0 | — |
Legal name
Arta Medical AB
Org number
5568302235
Legal form
Aktiebolag
NACE code
6491 · Financial leasing
Founded
7 december 2010
Share capital
SEK 200 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva utveckling, produktion och försäljning av medicintekniska produkter och leasingverksamhet av produktionsutrustning inom det medicintekniska området samt därmed förenlig verksamhet.
Address
Antennvägen 1 A
Email
helge.steg@atraplast.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 800 | 1 716 | 1 752 | 2 700 | 1 979 |
| Staff expenses | — | — | — | −0 | — |
| EBITDA | 769 | 684 | 654 | 712 | 173 |
| Depreciation & amort. | −759 | −679 | −679 | −629 | −99 |
| EBIT | 10 | 5 | −25 | 83 | 74 |
| Net financials | −34 | 1 | 6 | 8 | −1 |
| Profit before tax | 318 | 259 | 271 | 384 | 283 |
| Tax | −72 | −53 | −56 | −80 | −58 |
| Net profit | 246 | 206 | 215 | 305 | 225 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13 090 | 10 604 | 10 475 | 2 335 | 2 284 |
| Equity | 9 029 | 9 236 | 9 450 | 1 755 | 1 980 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 2 902 | 496 | 494 | 342 | 304 |
| Total debt | 2 902 | 496 | 494 | 342 | 304 |
EBITDA margin
8.7%
This company
15.8%
Market median
-45% vs market
20212025
Equity ratio
86.7%
This company
38.2%
Market median
+127% vs market
20212025
Return on equity
11.4%
This company
18.4%
Market median
+38% vs market
20212025
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20212025
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
20212025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EA Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Artapac Aktiebolag
Arta Medical AB Board members of Arta Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Adrian Emilsson | Chief Auditor | 0 companies |
| Bo Josef Kristian Östlund | Deputy Board Member | 0 companies |
| Helge Wolfgang Steg | Board of Directors | 0 companies |